Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Open Access
- 30 January 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 266-273
Abstract
Objectives: Angiogenesis is involved in polycystic ovary syndrome (PCOS) progression. Vascular endothelial growth factor-C (VEGF-C) and its receptors are key angiogenic markers. The main objective of this study was to investigate the serum levels of VEGF-C and its receptors, soluble VEGF receptor 2 (sVEGFR-2) and VEGFR-3, in patients with PCOS and healthy controls and determine the link between serum levels of these VEGF-related proteins and the biochemical and hormonal data of patients with PCOS. Methods: Thirty-six women with PCOS and 30 controls were included in this study. The measurement of VEGF-C, sVEGFR-2, and VEGFR-3 levels in serum and routine biochemical and hormone analysis were performed. Results: In the PCOS group, significantly higher serum sVEGFR-2 levels and no significant differences in serum VEGF-C and VEGFR-3 were observed compared to the controls. Serum sVEGFR-2 levels exhibited positive associations with VEGF-C, VEGFR-3, total cholesterol, and anti-müllerian hormone (AMH) in women with PCOS. Moreover, a positive correlation between serum VEGF-C and VEGFR-3 concentrations was detected in patients with PCOS. The cutoff value of serum sVEGFR-2 was 4.24 ng/mL (sensitivity 68 %, specificity 64 %) to distinguish PCOS. Conclusions: Despite unaltered levels of serum VEGF-C and VEGFR-3, there was an association between circulating levels of sVEGFR-2 and these VEGF-related proteins. sVEGFR-2 could be a promising diagnostic biomarker for PCOS. Regarding the significant correlation between sVEGFR-2 and AMH, sVEGFR-2 could have an impact on the hormonal elements of PCOS. Further studies are warranted to fully understand the function of VEGF-C and its receptors in PCOS.Keywords
This publication has 43 references indexed in Scilit:
- Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human SubjectsPLOS ONE, 2011
- Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic TherapiesGenes & Cancer, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistanceAtherosclerosis, 2010
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growthNature Medicine, 2009
- Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levelsFertility and Sterility, 2008
- Vascular Endothelial Growth Factor–Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor GrowthCancer Research, 2008
- Biology of vascular endothelial growth factorsFEBS Letters, 2006
- Angiogenic factors are elevated in overweight and obese individualsInternational Journal of Obesity, 2005
- Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesJournal of Biological Chemistry, 1997